| dc.contributor.author | Atukunda, Esther Cathyln | |
| dc.contributor.author | Brhlikova, Petra | |
| dc.contributor.author | Agaba, Amon Ganafa | |
| dc.contributor.author | Pollock, Allyson M | |
| dc.date.accessioned | 2022-08-08T08:23:21Z | |
| dc.date.available | 2022-08-08T08:23:21Z | |
| dc.date.issued | 2013 | |
| dc.identifier.citation | Atukunda, E. C., Brhlikova, P., Agaba, A. G., & Pollock, A. M. (2013). Registration, procurement, distribution, and use of misoprostol in Uganda: an interview-based observational study. The Lancet, 382, 10. | en_US |
| dc.identifier.uri | http://ir.must.ac.ug/xmlui/handle/123456789/2344 | |
| dc.description.abstract | Background: Poor access to essential medicines remains a barrier to improvement of health in low-income countries. The maternal mortality rate from post-partum haemorrhage (PPH) in Uganda is one of the highest in the world. Uganda launched a misoprostol rollout programme for prevention of PPH in 2009, before WHO added it to the Essential Medicines List. We assessed the rollout programme in Uganda. | en_US |
| dc.description.sponsorship | European Union | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | The Lancet | en_US |
| dc.subject | Registration | en_US |
| dc.subject | Procurement | en_US |
| dc.subject | Distribution | en_US |
| dc.subject | Use of misoprostol | en_US |
| dc.subject | Uganda | en_US |
| dc.title | Registration, procurement, distribution, and use of misoprostol in Uganda: an interview-based observational study | en_US |
| dc.type | Article | en_US |
